Phone: +44 141 899 0081

Archive

Home / Tag: Off-label drug

Adaptive Pathways, Biosimilars, Rare Diseases – ISPOR 19th Annual European Congress – 29 Oct-2 Nov 2016, Vienna, Austria

Adaptive Pathways and Patient AccessAn issue panel entitled Adaptive Pathways and Patient Access: Pushing Payer Boundaries or Facilitating New Payment Models? was held and moderated by Jacoline Bouvy, Scientific Adviser, National Institute for Health and Care Excellence (NICE), London, UK. Jacoline